BioAge Labs Inc. (BIOA) vs CAMP4 Therapeutics Corporation (CAMP)
A side-by-side comparison of BioAge Labs Inc. and CAMP4 Therapeutics Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BIOA
BioAge Labs Inc.
$6.13HealthcareDelayed quote: Oct 6, 2026, 1:05 PM EDT
CAMP
CAMP4 Therapeutics Corporation
$3.83HealthcareDelayed quote: Oct 6, 2026, 1:04 PM EDT
Total return — BIOA vs CAMP
growth of $100 · dividends reinvested · last 2yBIOA -70.7% (-45.9%/yr)CAMP -62.6% (-38.8%/yr)CAMP compounded faster over this window
BIOA CAMP
BIOA vs CAMP: by the numbers
- •CAMP is the larger company ($240M vs $231M market cap).
- •Both run net losses; BIOA's is the smaller (-912.25% vs -2543.74% net margin).
Metrics side by side
Valuation
| Metric | BIOA | CAMP |
|---|---|---|
| P/S ratio | 22.29 | 57.01 |
| P/B ratio | 0.62 | N/A |
Profitability
| Metric | BIOA | CAMP |
|---|---|---|
| Gross margin | 99.39% | 53.14% |
| Operating margin | -1026.28% | -1488.31% |
| Net margin | -912.25% | -2543.74% |
| ROE | -25.20% | N/A |
| ROIC | -28.14% | -69.76% |
Growth (annualized)
| Metric | BIOA | CAMP |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -57.68% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.